ORCID Profile
0000-0003-2739-3222
Current Organisations
ETH Zurich
,
Empa
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Wiley
Date: 24-07-2017
Publisher: Springer Science and Business Media LLC
Date: 06-01-2021
Publisher: American Chemical Society (ACS)
Date: 30-08-2017
DOI: 10.1021/ACS.BIOMAC.7B00792
Abstract: Amyloid fibrils prepared from β-lactoglobulin were used to form freeze-dried and cross-linked aerogels. By varying the fibril concentration and freezing gradient, it was possible to control the pore structure and elastic modulus of the aerogels within one order of magnitude from ∼20 to ∼200 kPa. Using butane tetracarboxylic acid as cross-linker, these aerogels maintained their monolithic shape under aqueous conditions, displaying elastic behavior and a modulus in the range of ∼4-40 kPa. When explored as scaffolds for cell growth, the amyloid fibril aerogels demonstrated biocompatibility and led to the successful penetration and permeation of two epithelial cell lines (Caco-2 and HT29) throughout the scaffold. These soft, elastic, and water-stable biomaterials expand the scope of amyloid fibril aerogels, making them suitable for wet-state applications such as heterogeneous catalysis, purification membranes, and 3D matrices for cell growth.
Publisher: Springer Science and Business Media LLC
Date: 24-04-2017
Abstract: Iron-deficiency anaemia (IDA) is a major global public health problem. A sustainable and cost-effective strategy to reduce IDA is iron fortification of foods, but the most bioavailable fortificants cause adverse organoleptic changes in foods. Iron nanoparticles are a promising solution in food matrices, although their tendency to oxidize and rapidly aggregate in solution severely limits their use in fortification. Amyloid fibrils are protein aggregates initially known for their association with neurodegenerative disorders, but recently described in the context of biological functions in living organisms and emerging as unique biomaterial building blocks. Here, we show an original application for these protein fibrils as efficient carriers for iron fortification. We use biodegradable amyloid fibrils from β-lactoglobulin, an inexpensive milk protein with natural reducing effects, as anti-oxidizing nanocarriers and colloidal stabilizers for iron nanoparticles. The resulting hybrid material forms a stable protein-iron colloidal dispersion that undergoes rapid dissolution and releases iron ions during acidic and enzymatic in vitro digestion. Importantly, this hybrid shows high in vivo iron bioavailability, equivalent to ferrous sulfate in haemoglobin-repletion and stable-isotope studies in rats, but with reduced organoleptic changes in foods. Feeding the rats with these hybrid materials did not result in abnormal iron accumulation in any organs, or changes in whole blood glutathione concentrations, inferring their primary safety. Therefore, these iron-amyloid fibril hybrids emerge as novel, highly effective delivery systems for iron in both solid and liquid matrices.
No related grants have been discovered for Gustav Nystrom.